133 related articles for article (PubMed ID: 9556673)
1. Drug interaction triggers weakness.
Lilley LL; Guanci R
Am J Nurs; 1998 Apr; 98(4):10. PubMed ID: 9556673
[No Abstract] [Full Text] [Related]
2. [Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
Valero R; Rodrigo E; Zubimendi JA; Arias M
Nefrologia; 2004; 24(4):382-3. PubMed ID: 15455502
[No Abstract] [Full Text] [Related]
3. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy.
Wong PW; Dillard TA; Kroenke K
South Med J; 1998 Feb; 91(2):202-5. PubMed ID: 9496876
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
Landesman KA; Stozek M; Freeman NJ
Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
DiGregorio RV; Pasikhova Y
Pharmacotherapy; 2009 Mar; 29(3):352-6. PubMed ID: 19249953
[TBL] [Abstract][Full Text] [Related]
6. [88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
Arnold Ch; Lamy O; Hagmann N
Praxis (Bern 1994); 2010 Dec; 99(24):1507-11. PubMed ID: 21125536
[TBL] [Abstract][Full Text] [Related]
7. Drug-interaction-induced rhabdomyolysis.
Segaert MF; De Soete C; Vandewiele I; Verbanck J
Nephrol Dial Transplant; 1996 Sep; 11(9):1846-7. PubMed ID: 8918636
[No Abstract] [Full Text] [Related]
8. Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin.
Grunden JW; Fisher KA
Ann Pharmacother; 1997; 31(7-8):859-63. PubMed ID: 9220046
[TBL] [Abstract][Full Text] [Related]
9. [Rhabdomyolysis in a patient treated with lovastatin and cyclosporine].
Hermida Lazcano I; Revillo Pinilla P; Nerin Sánchez C; Lechuga Durán I; Fernández López J
An Med Interna; 1997 Sep; 14(9):488. PubMed ID: 9453765
[No Abstract] [Full Text] [Related]
10. Rhabdomyolysis associated with lovastatin and erythromycin use.
Spach DH; Bauwens JE; Clark CD; Burke WG
West J Med; 1991 Feb; 154(2):213-5. PubMed ID: 2006579
[No Abstract] [Full Text] [Related]
11. [Rhabdomyolysis due to simvastin. Apropos of a case with review of the literature].
Dromer C; Vedrenne C; Billey T; Pages M; Fournié B; Fournié A
Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):281-3. PubMed ID: 1496277
[TBL] [Abstract][Full Text] [Related]
12. Frequency of myopathy in patients receiving lovastatin.
Wortmann RL; Tipping RW; Levine JG; Melin JM
Am J Cardiol; 2005 Apr; 95(8):983-5. PubMed ID: 15820170
[TBL] [Abstract][Full Text] [Related]
13. [Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Vera M; Pou M; Botey A; Cases A
Nefrologia; 2001; 21(6):613-4. PubMed ID: 11881437
[No Abstract] [Full Text] [Related]
14. [Acute rhabdomyolysis during treatment with simvastatin (Zocor)].
Bertrand F; Fournier JP; Martinez P; Mahagne MH; Chichmanian RM; Ducoeur S; Lefebvre M; Avril E
Therapie; 1992; 47(5):442. PubMed ID: 1299994
[No Abstract] [Full Text] [Related]
15. [Interactions between statins and macrolide antibiotics].
Molden E; Andersson KS; Jacobsen D
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1660-1. PubMed ID: 17571108
[No Abstract] [Full Text] [Related]
16. Lovastatin and rhabdomyolysis.
Ayanian JZ; Fuchs CS; Stone RM
Ann Intern Med; 1988 Oct; 109(8):682-3. PubMed ID: 3421582
[No Abstract] [Full Text] [Related]
17. Lovastatin-associated rhabdomyolysis.
Sylvain-Moore H; Worden JP
Heart Lung; 1991 Sep; 20(5 Pt 1):464-6. PubMed ID: 1894526
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
Molden E; Andersson KS
Pharmacotherapy; 2007 Apr; 27(4):603-7. PubMed ID: 17381388
[TBL] [Abstract][Full Text] [Related]
19. Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibozil.
Knoll RW; Ciafone R; Galen M
Conn Med; 1993 Sep; 57(9):593-4. PubMed ID: 8252847
[No Abstract] [Full Text] [Related]
20. Myotoxicity of lipid-lowering agents in a teenager with MELAS mutation.
Tay SK; Dimauro S; Pang AY; Lai PS; Yap HK
Pediatr Neurol; 2008 Dec; 39(6):426-8. PubMed ID: 19027590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
